Natural Killer Cell Immune Synapse Formation and Cytotoxicity Are Controlled by Tension of the Target Interface
Overview
Authors
Affiliations
Natural killer (NK) cells can kill infected or transformed cells via a lytic immune synapse. Diseased cells may exhibit altered mechanical properties but how this impacts NK cell responsiveness is unknown. We report that human NK cells were stimulated more effectively to secrete granzymes A and B, FasL (also known as FasLG), granulysin and IFNγ, by stiff (142 kPa) compared to soft (1 kPa) planar substrates. To create surrogate spherical targets of defined stiffness, sodium alginate was used to synthesise soft (9 kPa), medium (34 kPa) or stiff (254 kPa) cell-sized beads, coated with antibodies against activating receptor NKp30 (also known as NCR3) and the integrin LFA-1 (also known as ITGAL). Against stiff beads, NK cells showed increased degranulation. Polarisation of the microtubule-organising centre and lytic granules were impaired against soft targets, which instead resulted in the formation of unstable kinapses. Thus, by varying target stiffness to characterise the mechanosensitivity of immune synapses, we identify soft targets as a blind spot in NK cell recognition. This article has an associated First Person interview with the co-first authors of the paper.
Tumor cells escape immunosurveillance by hampering LFA-1.
Upadhyay S, Murugu L, Svensson L Front Immunol. 2025; 16:1519841.
PMID: 39911389 PMC: 11794523. DOI: 10.3389/fimmu.2025.1519841.
Peng H, Chao Z, Wang Z, Hao X, Xi Z, Ma S Exp Hematol Oncol. 2025; 14(1):4.
PMID: 39799341 PMC: 11724500. DOI: 10.1186/s40164-024-00591-7.
Underappreciated layers of antibody-mediated immune synapse architecture and dynamics.
Goldberg B, Ackerman M mBio. 2024; 16(1):e0190024.
PMID: 39660921 PMC: 11708040. DOI: 10.1128/mbio.01900-24.
de Jesus M, Settle A, Vorselen D, Gaetjens T, Galiano M, Romin Y Sci Immunol. 2024; 9(96):eadj2898.
PMID: 38941478 PMC: 11826491. DOI: 10.1126/sciimmunol.adj2898.
Natural Killer Cell Mechanosensing in Solid Tumors.
Lightsey S, Sharma B Bioengineering (Basel). 2024; 11(4).
PMID: 38671750 PMC: 11048000. DOI: 10.3390/bioengineering11040328.